How to monitor musculoskeletal manifestations of neurofibromatosis type-1 and tuberous sclerosis ESSR 2022 Skills Posted on September 18, 2023 ← Seronegative SpA and its treatment monitoring DECT in diagnosing and monitoring crystal deposition arthritis →